S&P 500 7,637.76 +1.14%
Nasdaq 26,418.30 +1.69%
S&P/TSX 35,874.26 +1.08%
Apple 337.00 +1.38%
Nvidia 219.34 +2.54%
Microsoft 497.75 +1.52%
Shopify 180.01 −0.97%
Royal Bank 284.93 +0.66%
CAD/USD 0.7154 +0.07%
CLOSED · 00:00 ET
Market ClerkRecap
Fri Sep 18 · markets closed3 signals on Sep 17300 insider buys this week · $205.1MCIRO short report next: Sep 29The week ahead
RW
INSIDER · TVTX · Travere Therapeutics, Inc. · CHIEF RESEARCH OFFICER

ROTE WILLIAM E.

Every open-market transaction filed under this name, Sep 15 to Sep 16.

Filings
6
0 buys · 6 sells
Bought
open market, at cost
Sold
$13.1M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 16TVTXTravere Therapeutics, Inc.Chief Research OfficerSell47,746$63.61$3M−1.7%
Sep 16TVTXTravere Therapeutics, Inc.Chief Research OfficerSell65,104$63.12$4.1M−1.0%
Sep 15TVTXTravere Therapeutics, Inc.Chief Research OfficerSell270$65.31$18K−4.3%
Sep 15TVTXTravere Therapeutics, Inc.Chief Research OfficerSell3,000$63.65$191K−1.8%
Sep 15TVTXTravere Therapeutics, Inc.Chief Research OfficerSell29,021$62.66$1.8M−0.2%
Sep 15TVTXTravere Therapeutics, Inc.Chief Research OfficerSell63,907$61.99$4M+0.8%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.